7 results
IDSA Aspergillosis Treatment
 • Invasive pulmonary aspergillosis (IPA)
 • CNS aspergillosis
 • Cardiac Aspergillus infection
 •
IDSA Aspergillosis ... Treatment • Invasive ... of eye Infectious ... #management #pharmacology ... #IDSA
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... Enteric Infections ... #IDSA #Prevention ... #Treatment #management ... #HIVAIDS #pharmacology
Hematuria in Post-Renal Transplant Patient
Prevalence up to 12% in the postrenal transplant patient
 • Bacterial: Escherichia
transplant patient • Bacterial ... Virus • Fungal: Candida ... : Secondary to infections ... #blood #urine #management ... #treatment #nephrology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... #Candidiasis #candida ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
Tularemia - Diagnosis and Management Summary
Francisella tularensis - Aerobic fastidious gram-negative Coccobacillus - Zoonotic Infection
 •
Diagnosis and Management ... Coccobacillus - Zoonotic Infection ... Splashing infected material ... into eye; unilateral ... Culture & GS, PCR Treatment
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
IDSA Recommendations ... contralateral eye ... Cytomegalovirus #CMV #IDSA ... #management #opportunistic ... #pharmacology
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
IDSA Recommendations ... with positive serology ... #Prevention #Treatment ... #management #opportunistic ... #pharmacology